CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-30 | Katkin Keith Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2017-05-24 | FLESHER GREGORY J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2017-05-24 | TURKEL CATHERINE C. Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +52,500 | 52,500 | ||
| 2017-05-24 | OCAMPO CHRISTINE See Remarks | Grant or award · Stock Option (Right to Buy) | +52,500 | 52,500 | ||
| 2017-05-10 | FLESHER GREGORY J. Chief Executive Officer | Purchase | +58,959 | $9.99 | $589K | 115,856 |
| 2017-05-10 | TURKEL CATHERINE C. Chief Development Officer | Purchase | +11,111 | $9.99 | $111K | 24,519 |
| 2017-05-10 | OCAMPO CHRISTINE See Remarks | Purchase | +10,010 | $9.99 | $100K | 21,590 |
| 2017-05-09 | OrbiMed Israel GP Ltd. Director | Grant or award | +2,537,110 | 2,537,110 | ||
| 2016-06-16 | Cohen Cheryl Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2016-06-15 | Yanchik Joseph A., III Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2016-06-15 | Kessler David A. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2016-06-15 | Buckley Stephen Jr. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2016-06-15 | BARBERICH TIMOTHY J Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2016-06-15 | Harrison Seth Loring Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2016-03-15 | Buckley Stephen Jr. Director | Purchase | +8,000 | $5.74 | $46K | 11,000 |
| 2016-01-08 | Morrison Jodie Pope President and CEO | Option exercise | +8,015 | $0.63 | $5K | 37,566 |
| 2016-01-08 | Morrison Jodie Pope President and CEO | Option exercise | +20,000 | $1.37 | $27K | 57,566 |
| 2016-01-08 | Morrison Jodie Pope President and CEO | Option exercise · Stock Option (right to buy) | −8,015 | 0 | ||
| 2016-01-08 | Morrison Jodie Pope President and CEO | Option exercise · Stock Option (right to buy) | −20,000 | 37,878 | ||
| 2015-12-15 | Ferrante Karen Jean Head Res. & Dev. & Chief Med. | Grant or award · Stock Option (right to buy) | +62,000 | 62,000 |
Page 10 of 15 · 300 trades